Australia's largest stock trading and investment forum Australia's #1 stock forum

DXB

Click for more information

1.08%

46.0¢ dimerix limited

This is an in vitro study, hence no requirements. Obviously...

First 61 Last

Share
Profile

Follow
HS2912

47 Posts.

11

26/03/21

07:16

Post #: 52053216
Share

Originally posted by Owl vs Fox: ↑

GMP is required for all human clinical trials & manufacture of drugs! DXB already have upscaled GMP & FDA approved manufacturing of DMX-200 in the USA for COVID-19 trials via an approved Pharma for patient needs & not considering upcoming renal disease trials, you are potentially looking at dosing for 1000 patients, just to cover the initial 200 in REMAP CAP & move to Ph3, then 600 in CLARITY-2.0, and then all the patients that remain on Special Access Scheme via scripts from their treating Physicians (coming up to>4 years now for some patients from Ph2A, these ones were sicker, you are looking at a potential diversion from dialysis right here. The FDA requirements for approval were started way back in 2019 for packaging, shelf life stability, all those things required were done prior to Ph2. TGA obviously happy with SAS earlier on & not many drugs are given the ok this way, there has to be very good evidence. That data is sitting there now for PH3 & open label.

Not sure what you are talking about @HS2912??

GLTAH

Expand

This is an in vitro study, hence no requirements. Obviously different story if it was in humans...

DXB Price at posting: 26.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

IVZ

Invictus banks US$5M from Zimbabwean investment fund in support of Cabora Bassa

BIO

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

AZL

Brine and shine: Arizona Lithium wins early stage eco approval to commence wellpad #2 at Prairie

BOE

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

PAM

PAM secures high-grade Chilean copper play in strong territory

There are more pages in this discussion • 6 more messages in this thread...

First 61 Last

Add DXB (ASX) to my watchlist

(20min delay)
Last 46.0¢		Change -0.005(1.08%)		Mkt cap ! $253.1M

Open	High	Low	Value	Volume
47.0¢	49.0¢	45.5¢	$1.771M	3.761M

Buyers (Bids)

No.	Vol.	Price($)
1	34765	46.0¢

Sellers (Offers)

Price($)	Vol.	No.
46.5¢	26998	1

View Market Depth

No.	Vol.	Price($)
1	34765	0.460
1	27490	0.455
11	139304	0.450
6	137675	0.445
9	106127	0.440

Price($)	Vol.	No.
0.465	26998	1
0.470	76998	2
0.475	60000	2
0.480	128862	3
0.485	243016	4

Last trade - 16.10pm 29/07/2024 (20 minute delay)

DXB (ASX) Chart